Skip to main content
Clinical Trials/NCT02697019
NCT02697019
Completed
N/A

Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study

Karolinska Institutet1 site in 1 country25 target enrollmentFebruary 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Nonsuicidal Self-Injury
Sponsor
Karolinska Institutet
Enrollment
25
Locations
1
Primary Endpoint
Deliberate Self-Harm Inventory - 9 item version
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The primary aim is to investigate the effectiveness of an Internet-delivered Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury (NSSI).

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
December 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Clara Hellner Gumpert

PhD

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • A primary diagnosis of NSSI as defined in Section 3 in the fifth edition of the Diagnostic and Statistical Manual 5 of the American Psychiatric Association (DSM-5) \< 1 NSSI episode during the past month At least one parent needs to commit to participate in the parent program

Exclusion Criteria

  • Bipolar disorder I or primary psychosis Severe suicidal ideation Ongoing substance dependence Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse) insufficient Swedish language skills Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)

Outcomes

Primary Outcomes

Deliberate Self-Harm Inventory - 9 item version

Time Frame: Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up

Change from baseline in self-harming behaviors when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended

Secondary Outcomes

  • Acceptance and Action Questionnaire (AAQ-7)(Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up])
  • The Revised Child Anxiety and Depression Scale - Child and Parent rated (RCADS-C)(Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up])
  • Borderline Symptom List Behavior supplement (BSL-supplement)(Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up)
  • Difficulties in Emotion Regulation Scale -16 item version (DERS-16)(Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up)
  • Difficulties in Emotion Regulation Scale (DERS)(Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up])
  • Borderline personality features in childhood (BPFS-C)(Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up])
  • Suicidal Ideation Questionnaire (SIQ-JR)(Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up])

Study Sites (1)

Loading locations...

Similar Trials